✦ LIBER ✦

Natural interferon-β treatment of relapsing—remitting and secondary-progressive multiple sclerosis patients. A two-year study

✍ Scribed by F. Patti; M. R. L'Episcopo; M. L. Cataldi; A. Reggio

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Interferon-β treatment and the natural h

✍ Marcus Koch; Jop Mostert; Jacques De Keyser; Helen Tremlett; Graziella Filippini 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 51 KB 👁 1 views

Cost-utility of interferon β1bin the tre

✍ G. Kobelt; L. Jönsson; S. Fredrikson 📂 Article 📅 2003 🏛 Springer 🌐 French ⚖ 346 KB

Study of binding and neutralising antibo

✍ Oscar Fernández; Cristobalina Mayorga; Gloria Luque; Miguel Guerrero; Rocío Guer 📂 Article 📅 2001 🏛 Springer 🌐 English ⚖ 259 KB

Gray matter atrophy and disability progr

✍ Dana Horakova; Michael G. Dwyer; Eva Havrdova; Jennifer L. Cox; Ondrej Dolezal; 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 288 KB

Assessment of different treatment failur

✍ Jordi Río; Carlos Nos; Mar Tintoré; Cecilia Borrás; Ingrid Galán; Manuel Comabel 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 94 KB 👁 2 views

The long-term safety and tolerability of

✍ R. Gold; P. Rieckmann; P. Chang; J. Abdalla; the PRISMS Study Group 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 139 KB